# Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/beyond-frontline-therapy-with-abiraterone-and-enzalutamide-in-metastatic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Neal D. Shore,Raluca Ionescu‐Ittu,François Laliberté,Lingfeng Yang,Dominique Lejeune,Louise Yu,Mei Sheng Duh,Malena Mahendran,Jeri Kim,Sameer R. Ghate |
| Citations | 20 |
| DOI | 10.1016/j.clgc.2021.07.009 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.clgc.2021.07.009 |
| OpenAlex ID | https://openalex.org/W3179582685 |
| PMID | 34373223 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Malena Mahendran](https://scholariq.org/researchers/malena-mahendran/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.